BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11200800)

  • 1. Pharmacology of emesis and gastrointestinal motility: implications for migraine.
    De Ponti F
    Funct Neurol; 2000; 15 Suppl 3():43-9. PubMed ID: 11200800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiology and pharmacology of migraine. Is there a place for antiemetics in future treatment strategies?
    Dahlöf CG; Hargreaves RJ
    Cephalalgia; 1998 Nov; 18(9):593-604. PubMed ID: 9876882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Migraine-associated symptoms: clinical significance and management.
    Becker WL
    Can J Clin Pharmacol; 1999; 6 Suppl A():15A-9A. PubMed ID: 10494007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Domperidone: a peripherally acting dopamine2-receptor antagonist.
    Barone JA
    Ann Pharmacother; 1999 Apr; 33(4):429-40. PubMed ID: 10332535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Domperidone, a new dopamine antagonist.
    Champion MC; Hartnett M; Yen M
    CMAJ; 1986 Sep; 135(5):457-61. PubMed ID: 3527396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric motor effects of triptans: open questions and future perspectives.
    Cipolla G; Sacco S; Crema F; Moro E; De Ponti F; Frigo G
    Pharmacol Res; 2001 Mar; 43(3):205-10. PubMed ID: 11401410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonism of cisplatin-induced emesis by metoclopramide and dazopride through enhancement of gastric motility.
    Alphin RS; Proakis AG; Leonard CA; Smith WL; Dannenburg WN; Kinnier WJ; Johnson DN; Sancilio LF; Ward JW
    Dig Dis Sci; 1986 May; 31(5):524-9. PubMed ID: 3698769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed absorption of many (paracetamol, aspirin, other NSAIDs and zolmitriptan) but not all (sumatriptan, rizatriptan) drugs during migraine attacks and most likely normal gastric emptying outside attacks. A review.
    Tfelt-Hansen PC
    Cephalalgia; 2017 Aug; 37(9):892-901. PubMed ID: 27330004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prokinetic drugs in digestive disorders].
    Carella G; Marra L
    Clin Ter; 1993 Sep; 143(3):219-24. PubMed ID: 8222553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional localization of specific receptors mediating gastrointestinal motor correlates of vomiting.
    Lang IM; Marvig J
    Am J Physiol; 1989 Jan; 256(1 Pt 1):G92-9. PubMed ID: 2563202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of clonidine and sumatriptan on postprandial gastric volume response, antral contraction waves and emptying: an MRI study.
    Kwiatek MA; Fox MR; Steingoetter A; Menne D; Pal A; Fruehauf H; Kaufman E; Forras-Kaufman Z; Brasseur JG; Goetze O; Hebbard GS; Boesiger P; Thumshirn M; Fried M; Schwizer W
    Neurogastroenterol Motil; 2009 Sep; 21(9):928-e71. PubMed ID: 19413683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the anti-emetic potential of anti-migraine drugs to prevent resiniferatoxin-induced emesis in Suncus murinus (house musk shrew).
    Cheng FH; Andrews PL; Moreaux B; Ngan MP; Rudd JA; Sam TS; Wai MK; Wan C
    Eur J Pharmacol; 2005 Jan; 508(1-3):231-8. PubMed ID: 15680276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
    Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS
    Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zelrix: a novel transdermal formulation of sumatriptan.
    Pierce M; Marbury T; O'Neill C; Siegel S; Du W; Sebree T
    Headache; 2009 Jun; 49(6):817-25. PubMed ID: 19438727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An orally active motilin receptor antagonist, MA-2029, inhibits motilin-induced gastrointestinal motility, increase in fundic tone, and diarrhea in conscious dogs without affecting gastric emptying.
    Ozaki K; Onoma M; Muramatsu H; Sudo H; Yoshida S; Shiokawa R; Yogo K; Kamei K; Cynshi O; Kuromaru O; Peeters TL; Takanashi H
    Eur J Pharmacol; 2009 Aug; 615(1-3):185-92. PubMed ID: 19445919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current role of antidopaminergic drugs in pediatrics].
    Cinquetti M; Bonetti P; Bertamini P
    Pediatr Med Chir; 2000; 22(1):1-7. PubMed ID: 11387760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azaadamantane benzamide 5-HT4 agonists: gastrointestinal prokinetic SC-54750.
    Becker DP; Flynn DL; Shone RL; Gullikson G
    Bioorg Med Chem Lett; 2004 Nov; 14(22):5509-12. PubMed ID: 15482914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Migraine and gastroparesis from a gastroenterologist's perspective.
    Parkman HP
    Headache; 2013 Jun; 53 Suppl 1():4-10. PubMed ID: 23721284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced gastrointestinal motility with orally active ghrelin receptor agonists.
    Charoenthongtrakul S; Giuliana D; Longo KA; Govek EK; Nolan A; Gagne S; Morgan K; Hixon J; Flynn N; Murphy BJ; Hernández AS; Li J; Tino JA; Gordon DA; DiStefano PS; Geddes BJ
    J Pharmacol Exp Ther; 2009 Jun; 329(3):1178-86. PubMed ID: 19252061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prokinetics and fundic relaxants in upper functional GI disorders.
    Tack J
    Curr Opin Pharmacol; 2008 Dec; 8(6):690-6. PubMed ID: 18940266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.